ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 16,020
+1,280 (8.68%)
Apr 1, 2026, 3:30 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 175.65 billion as of April 1, 2026. Its market cap has decreased by -14.89% in one year.
Market Cap
175.65B
Enterprise Value
150.16B
Revenue
5.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,020.00
Market Cap Chart
Since August 23, 2024, ENCell's market cap has increased from 160.82B to 175.65B, an increase of 9.22%. That is a compound annual growth rate of 5.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 161.62B | -18.58% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 283.40B |
| JETEMA, | 273.04B |
| HLB Therapeutics | 256.97B |
| EASY BIO,Inc. | 235.21B |
| Genexine | 210.57B |
| MedPacto | 191.94B |
| Vaxcell-Bio Therapeutics | 177.45B |
| Macrogen | 172.38B |